NL191387B - 4-substituted 3-keto steroids, pharmaceutical composition containing such a 3-ketosteroid, and method for its preparation. - Google Patents

4-substituted 3-keto steroids, pharmaceutical composition containing such a 3-ketosteroid, and method for its preparation.

Info

Publication number
NL191387B
NL191387B NL8002529A NL8002529A NL191387B NL 191387 B NL191387 B NL 191387B NL 8002529 A NL8002529 A NL 8002529A NL 8002529 A NL8002529 A NL 8002529A NL 191387 B NL191387 B NL 191387B
Authority
NL
Netherlands
Prior art keywords
ketosteroid
substituted
preparation
pharmaceutical composition
composition containing
Prior art date
Application number
NL8002529A
Other languages
Dutch (nl)
Other versions
NL8002529A (en
NL191387C (en
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NL8002529A publication Critical patent/NL8002529A/en
Publication of NL191387B publication Critical patent/NL191387B/en
Application granted granted Critical
Publication of NL191387C publication Critical patent/NL191387C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8002529A 1979-05-02 1980-05-01 4-substituted 3-keto steroids, pharmaceutical composition containing such a 3-ketosteroid, and method for its preparation. NL191387C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3535779A 1979-05-02 1979-05-02
US3535779 1979-05-02
US6974179A 1979-08-27 1979-08-27
US6974179 1979-08-27

Publications (3)

Publication Number Publication Date
NL8002529A NL8002529A (en) 1980-11-04
NL191387B true NL191387B (en) 1995-02-01
NL191387C NL191387C (en) 1995-07-03

Family

ID=26712031

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8002529A NL191387C (en) 1979-05-02 1980-05-01 4-substituted 3-keto steroids, pharmaceutical composition containing such a 3-ketosteroid, and method for its preparation.

Country Status (16)

Country Link
AT (1) AT390794B (en)
AU (1) AU532558B2 (en)
CA (1) CA1154008A (en)
CH (1) CH643863A5 (en)
DE (1) DE3017015A1 (en)
DK (1) DK166501B1 (en)
ES (1) ES8105012A1 (en)
FR (1) FR2455610A1 (en)
GB (1) GB2048888B (en)
IE (1) IE49704B1 (en)
IL (1) IL59934A (en)
IT (1) IT1188932B (en)
NL (1) NL191387C (en)
NO (1) NO154884C (en)
NZ (1) NZ193527A (en)
SE (1) SE448097B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
AU637247B2 (en) * 1990-08-01 1993-05-20 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
EP0794456B1 (en) 1996-03-07 2003-01-29 Agfa-Gevaert Method of reproducing an electronically stored medical image on a light-sensitive photographic material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917829A (en) * 1971-11-08 1975-11-04 Research Corp Novel methods of inhibiting the activity of testosterone 5{60 -reductase
US4088760A (en) * 1976-06-23 1978-05-09 Richardson-Merrell Inc. Testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
ES491010A0 (en) 1981-05-16
IT8048559A0 (en) 1980-04-30
GB2048888B (en) 1983-05-25
ATA232880A (en) 1989-12-15
NZ193527A (en) 1984-10-19
FR2455610A1 (en) 1980-11-28
ES8105012A1 (en) 1981-05-16
AU5774780A (en) 1980-11-06
IT8048559A1 (en) 1981-10-30
IT1188932B (en) 1988-01-28
CA1154008A (en) 1983-09-20
IE800806L (en) 1980-11-02
IL59934A0 (en) 1980-06-30
AU532558B2 (en) 1983-10-06
CH643863A5 (en) 1984-06-29
SE8003242L (en) 1980-11-03
IL59934A (en) 1983-06-15
NO154884B (en) 1986-09-29
NL8002529A (en) 1980-11-04
SE448097B (en) 1987-01-19
NL191387C (en) 1995-07-03
NO801254L (en) 1980-11-03
DE3017015A1 (en) 1980-11-20
FR2455610B1 (en) 1982-04-30
NO154884C (en) 1987-01-07
IE49704B1 (en) 1985-11-27
GB2048888A (en) 1980-12-17
AT390794B (en) 1990-06-25
DK194180A (en) 1980-11-03
DK166501B1 (en) 1993-06-01
DE3017015C2 (en) 1989-04-20

Similar Documents

Publication Publication Date Title
NL990037I2 (en) An isoxazole derivative, process for its preparation and agents containing this compound.
NL7800363A (en) NEW 4.9 DIEEN-11B SUBSTITUTED STEROID DERIVATIVES, METHOD FOR PREPARING THEM, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE STEROID DERIVATIVES.
NL191793C (en) Method for the preparation of a polypeptide, and of a pharmaceutical or veterinary preparation.
NL190818C (en) Method and reagent for the determination of alpha-amylase, as well as a method for the preparation of a maltoheptaose derivative.
NL7906287A (en) ERGOSTADIA TRIOLS, CONTAINING THESE COMPOSITIONS, AND METHODS FOR PREPARATION AND APPLICATION THEREOF.
NL190600B (en) PROCESS FOR THE PREPARATION OF A PROSTAGLANDINE COMPOUND (S) CONTAINING PHARMACEUTICAL PREPARATION, THE PREPARED PREPARATION SO GIVEN AND METHOD FOR THE PREPARATION OF THE COMPOUNDS USED THEREOF
NL184467C (en) 6-OXO-PROSTAGLANDIN EŸ1 DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DE3066434D1 (en) Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
NL187485C (en) PROSTAGLANDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATION.
NL181804C (en) SESQUITERPENE DERIVATIVES WITH ANTI-COMPLETION EFFECTS, METHOD FOR WINNING AN ANTI-COMPLETION EFFECTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NL187397B (en) PHARMACEUTICAL PREPARATIONS, 20,21-DINORO-BURNAMENINE COMPOUNDS THEREFOR AND METHOD FOR THEIR PREPARATION.
NL7903050A (en) METHOD OF PREPARING A MEDICINAL PRODUCT FOR CANCER, THE MEDICINAL PRODUCT THEREFORE, AND METHOD OF PREPARING THE MEDICINAL PLATINUM COMPOUND.
NL191387C (en) 4-substituted 3-keto steroids, pharmaceutical composition containing such a 3-ketosteroid, and method for its preparation.
NL190485B (en) ALFA-FLUORMETHYL-ALFA-AMINOALCANIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE SUCH COMPOUNDS, AND METHOD FOR PREPARING THE COMPOUNDS.
NL7811292A (en) PYRIDOXOL DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING IT.
NL192387B (en) Pure Silibinine Derivatives, Process for Their Preparation and Pharmaceutical Preparation Containing Such Derivative.
NL7603486A (en) METHOD OF PREPARING AN ANTIBIOTIC, AND ITS USE AS A PREPARATION FOR PROTECTING PLANTS.
NL187239C (en) N-SUBSTITUTED 2-CYANAZIRIDINE DERIVATIVE, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A PREPARATION.
NL7802826A (en) THIENAMYCINE DERIVATIVE, METHOD FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS.
NL7802380A (en) BENZYLPYRIMIDINES, A METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL184160B (en) IMIDAZOLE DERIVATIVES, PREPARATIONS CONTAINING THEM, AND METHOD FOR THE PREPARATION THEREOF
NL162643C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OBTAINED THEREOF, PREPARED PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF 5-FLUORAPYRIMIDINE COMPOUNDS.
NL7902268A (en) 2-HYDROXYMETHYLPYRAZINE DERIVATIVES AND A METHOD FOR THE PREPARATION THEREOF.
NL186699C (en) KANAMYCIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
NL187168C (en) 3 BETA-OXY-SUBSTITUTED-18 BETA-OLEAN-30-CARBOXY DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING ONE OR MORE OF THESE COMPOUNDS.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20000501